NCT00734864: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma |
|
|
| Withdrawn | 1 | 0 | US | enzyme-inducing anti-epileptic drugs | Annick Desjardins, Bristol-Myers Squibb | Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioma | 06/10 | 06/12 | | |
| Completed | 1 | 47 | US | Erlotinib and Dasatinib, Dasatinib, Erlotinib, Tarceva, Sprycel | Duke University, Bristol-Myers Squibb, Genentech, Inc. | Glioblastoma, Gliosarcoma | 07/10 | 07/10 | | |
